Medicare Enrolled

Dr. Richard Kim, M. D.

Medical Oncology · Tampa, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
12902 USF MAGNOLIA DR, Tampa, FL 33612
8137457365
In practice since 2006 (19 years)
NPI: 1609810779 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kim? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kim

Dr. Richard Kim is a medical oncology in Tampa, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kim performed 300 Medicare services across 204 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kim received a total of $718,939 from 49 pharmaceutical and/or device companies across 786 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kim is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 300 Medicare services$ $718,939 industry payments

Medicare Practice Summary

Medicare Utilization ↗
300
Medicare services
Bottom 25% in FL for medical oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
204
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)201$77$177
New patient office visit, complex (60-74 min)99$143$340
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$718,939
Total received (2018-2024)
Avg $102,706/year across 7 years
Top 2% in FL for medical oncology
49
Companies
786
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$478,700 (66.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$154,401 (21.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$85,837 (11.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$87,368
2023
$154,079
2022
$105,001
2021
$148,365
2020
$38,911
2019
$50,630
2018
$134,584

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Incyte Corporation
$135,264
Taiho Oncology, Inc.
$91,410
Lilly USA, LLC
$74,019
AstraZeneca Pharmaceuticals LP
$72,668
Bayer HealthCare Pharmaceuticals Inc.
$37,466
Exelixis Inc.
$33,341
ABBVIE INC.
$28,422
Merck Sharp & Dohme Corporation
$25,045
Eisai Inc.
$22,584
ARRAY BIOPHARMA INC
$21,855
PFIZER INC.
$21,567
EISAI INC.
$21,109
Servier Pharmaceuticals LLC
$16,428
Bayer Healthcare Pharmaceuticals Inc.
$15,147
Ipsen Biopharmaceuticals, Inc
$13,613
E.R. Squibb & Sons, L.L.C.
$13,501
Genentech USA, Inc.
$11,892
TAIHO ONCOLOGY, INC.
$11,520
Takeda Pharmaceuticals U.S.A., Inc.
$10,690
GlaxoSmithKline, LLC.
$9,143
Agios Pharmaceuticals, Inc.
$5,710
Pharmacosmos Therapeutics Inc.
$5,179
Pfizer Inc.
$4,149
JAZZ PHARMACEUTICALS INC.
$3,821
Merck Sharp & Dohme LLC
$2,420
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,220
Lexicon Pharmaceuticals, Inc.
$1,762
SANOFI-AVENTIS U.S. LLC
$1,568
Coherus Biosciences Inc.
$1,200
Medtronic, Inc.
$901
SERVIER PHARMACEUTICALS LLC
$717
Foundation Medicine, Inc.
$413
Seagen Inc.
$272
Daiichi Sankyo Inc.
$245
Helsinn Therapeutics (U.S.), Inc.
$204
Cardiovascular Systems Inc.
$198
Deciphera Pharmaceuticals Inc.
$159
Sirtex Medical Inc
$135
AbbVie, Inc.
$125
Alexion Pharmaceuticals, Inc.
$120
Gilead Sciences, Inc.
$108
Baxter Healthcare
$103
AbbVie Inc.
$102
SEAGEN INC.
$100
Genentech, Inc.
$99
Eli Lilly and Company
$79
AngioDynamics, Inc.
$75
Covidien LP
$47
Array BioPharma Inc.
$24
Top 3 companies account for 41.8% of total payments
Associated products mentioned in payments ›
ALIMTA · Aliqopa · Avastin · BRAFTOVI · Braftovi · CABOMETYX · CYRAMZA · Cabometyx · Creon · DFS · Diamondback Coronary · Diamondback Peripheral · EMPRINT · ERBITUX · Endo GIA · Enhertu · FOUNDATIONONE · FRUZAQLA · IMFINZI · IMJUDO · JEMPERLI · KEYTRUDA · LIGASURE · LONSURF · LYNPARZA · LYTGOBI · Lenvima · Lonsurf · MEKTOVI · MONOFERRIC · NANOKNIFE · Nexavar · Non-Covered · ONIVYDE · OPDIVO · Onivyde · PEMAZYRE · QINLOCK · Resolute · SIGNIA · SIR-Spheres Microspheres · SOMATULINE DEPOT · Signia · Somatuline Depot · Stivarga · TAS-102 · TECENTRIQ · TIBSOVO · TRUSELTIQ · Tecentriq · Tibsovo · Trodelvy · VALCHLOR · Xermelo · ZALTRAP · ZEJULA · ZIIHERA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (67%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for medical oncology in FL.

Equivalent to $239,646 per 100 Medicare services performed
Looking for a medical oncology in Tampa?
Compare medical oncologys in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
66
Per 100K population
4.4
County median income
$75,011
Nearest hospital
TAMPA VA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kim is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kim experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kim performed 201 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kim receive payments from pharmaceutical companies?
Yes. Dr. Kim received a total of $718,939 from 49 companies across 786 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kim's costs compare to other medical oncologys in Tampa?
Dr. Kim's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →